ORGANOGENESIS HOLDINGS INC. Operating Lease, Weighted Average Discount Rate, Percent
ORGANOGENESIS HOLDINGS INC. (ORGO) had Operating Lease, Weighted Average Discount Rate, Percent of 4.94% as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2026-02-26
- 2025-12-31: Operating Lease, Weighted Average Discount Rate, Percent 4.94%.
- 2024-12-31: Operating Lease, Weighted Average Discount Rate, Percent 4.91%.
- 2024-06-30: Operating Lease, Weighted Average Discount Rate, Percent 4.75%.
- 2024-03-31: Operating Lease, Weighted Average Discount Rate, Percent 4.75%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2025-12-31 | 4.94% 10-K · filed 2026-02-26 |
| 2024-12-31 | 4.91% 10-K · filed 2026-02-26 |
| 2024-06-30 | 4.75% 10-Q · filed 2024-08-08 |
| 2024-03-31 | 4.75% 10-Q · filed 2024-05-09 |
| 2023-12-31 | 4.71% 10-K · filed 2025-02-27 |
| 2023-09-30 | 4.73% 10-Q · filed 2023-11-09 |
| 2023-06-30 | 4.77% 10-Q · filed 2023-08-09 |
| 2023-03-31 | 4.65% 10-Q · filed 2023-05-10 |
| 2022-12-31 | 4.61% 10-K · filed 2024-02-29 |
| 2022-09-30 | 4.62% 10-Q · filed 2022-11-09 |
| 2022-06-30 | 4.54% 10-Q · filed 2022-08-09 |
| 2022-03-31 | 4.53% 10-Q · filed 2022-05-10 |
| 2021-12-31 | 4.51% 10-K · filed 2023-03-01 |
| 2021-09-30 | 4.18% 10-Q · filed 2021-11-09 |
| 2021-06-30 | 4.19% 10-Q · filed 2021-08-09 |
| 2021-03-31 | 3.98% 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |